65.65 -1.05 (-1.57%)
Before hours: 7:59AM EST
|Bid||65.51 x 3100|
|Ask||66.70 x 900|
|Day's range||66.57 - 68.37|
|52-week range||56.56 - 85.97|
|Beta (5Y monthly)||0.53|
|PE ratio (TTM)||66.24|
|Earnings date||04 Feb 2021|
|Forward dividend & yield||2.72 (4.08%)|
|Ex-dividend date||14 Dec 2020|
|1y target est||73.11|
It's been a rocky past few months for the biotech, but is now a good time for investors to pull the trigger?
Diodes Incorporated (Nasdaq: DIOD) will host a conference call on Tuesday, February 16, 2021 at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss its fourth quarter and fiscal 2020 financial results.
The coronavirus pandemic has impacted lots of industries but it didn't slow down the pace of new drug approvals. The FDA greenlighted 59 new drugs last year, and 2021 is shaping up to be a big year too. Read on to see why new drugs from GlaxoSmithKline (NYSE: GSK), Gilead Sciences (NASDAQ: GILD), and Eli Lilly (NYSE: LLY) made the list.